Skip to main content

Poly Medicure Ltd

NSE: POLYMED BSE: 531768Healthcare

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

1,435
52W: ₹1182 — ₹2530
PE 41.9 · Book ₹285 · +404% vs book
Market Cap₹14,545 Cr
Stock P/E41.9Price to Earnings
ROCE18.2%Return on Capital
ROE14.2%Return on Equity
Div. Yield0.23%Face Value ₹5

Strengths

  • +Company is almost debt free.
  • +Company has delivered good profit growth of 26.5% CAGR over last 5 years

Shareholding Pattern

Promoters62.42%
FIIs5.92%
DIIs15.6%
Public16.08%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters66.02%62.56%3.562.44%0.162.44%62.44%62.42%0.062.42%62.42%
FIIs9.91%11.88%2.012.33%0.411.46%0.911.41%0.19.77%1.69.41%0.45.92%3.5
DIIs9.34%12.33%3.011.66%0.711.96%0.311.72%0.213.53%1.813.84%0.315.6%1.8
Public14.72%13.23%1.513.57%0.314.13%0.614.43%0.314.28%0.214.34%0.116.08%1.7

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales320321361367402411421384417419
Expenses237236264266290295305283305307
Operating Profit838497101113115116101111112
OPM %26%26%27%28%28%28%28%26%27%27%
Net Profit59617172878587888978
EPS ₹6.176.417.357.538.618.48.558.688.797.73

AI Insights

Revenue Trend

TTM revenue at ₹1,640Cr, up 2.4% YoY. OPM at 27%.

Debt Position

Borrowings at ₹226Cr. Debt-to-equity ratio: 0.08x. Healthy balance sheet.

Capex Cycle

CWIP at ₹83Cr (7% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 15.6% (+11.35pp change). FIIs: 5.92% (-9.69pp change). Promoters hold 62.42%.

Margin & Efficiency

ROCE declining from 33% (Mar 2014) to 18% (Mar 2025). Working capital days: 73.

Valuation

PE 41.9x with 18.2% ROCE. Price is 404% above book value of ₹285. Dividend yield: 0.23%.

Recent Announcements